Literature DB >> 29420201

Additional comment to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke.

Fabrizio Cantini1, Maurizio Benucci2.   

Abstract

Keywords:  ankylosing sdpondylitis; anti-tnf; psoriatic arthritis; rheumatoid arthritis; treatment

Year:  2018        PMID： 29420201     DOI： 10.1136/annrheumdis-2018-213044

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Real-world use of an etanercept biosimilar including selective versus automatic substitution in inflammatory arthritis patients: a UK-based electronic health records study.

Authors:  Roxanne Cooksey; Sinead Brophy; Jonathan Kennedy; Michael Seaborne; Ernest Choy
Journal:  Rheumatol Adv Pract       Date:  2022-07-27

2.  Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.

Authors:  Katie Bechman; Fang En Sin; Fowzia Ibrahim; Sam Norton; Faith Matcham; David Lloyd Scott; Andrew Cope; James Galloway
Journal:  RMD Open       Date:  2018-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.